CME Group (NASDAQ:CME) Price Target Raised to $230.00 at Raymond James

CME Group (NASDAQ:CME) had its price target hoisted by analysts at Raymond James from $225.00 to $230.00 in a research note issued to investors on Thursday, Stock Target Advisor reports. The firm presently has an “outperform” rating on the financial services provider’s stock. Raymond James’ price objective suggests a potential upside of 5.96% from the stock’s current price.

Other research analysts have also issued reports about the company. Berenberg Bank reissued a “hold” rating on shares of CME Group in a research report on Wednesday, September 15th. Morgan Stanley decreased their target price on CME Group from $229.00 to $217.00 and set an “equal weight” rating for the company in a research report on Friday, October 8th. Piper Sandler reaffirmed a “buy” rating and issued a $230.00 target price on shares of CME Group in a research report on Friday, October 1st. Atlantic Securities raised CME Group from a “neutral” rating to an “overweight” rating and set a $230.00 target price for the company in a research report on Tuesday, September 14th. Finally, TheStreet lowered CME Group from a “b” rating to a “c+” rating in a research report on Wednesday, August 18th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus target price of $212.71.

CME stock opened at $217.06 on Thursday. The stock has a 50-day moving average price of $198.35 and a 200-day moving average price of $206.58. CME Group has a 1-year low of $146.89 and a 1-year high of $221.82. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $77.95 billion, a PE ratio of 40.57 and a beta of 0.43.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 27th. The financial services provider reported $1.60 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.56 by $0.04. CME Group had a return on equity of 8.33% and a net margin of 41.64%. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same period last year, the company posted $1.38 EPS. The business’s quarterly revenue was up 2.7% on a year-over-year basis. On average, analysts forecast that CME Group will post 6.65 earnings per share for the current year.

In related news, Director Martin J. Gepsman sold 1,000 shares of the company’s stock in a transaction that occurred on Monday, September 13th. The stock was sold at an average price of $188.53, for a total value of $188,530.00. Following the transaction, the director now owns 24,468 shares in the company, valued at $4,612,952.04. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Sean Tully sold 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, August 24th. The shares were sold at an average price of $200.20, for a total value of $1,001,000.00. Following the completion of the transaction, the insider now owns 23,479 shares in the company, valued at approximately $4,700,495.80. The disclosure for this sale can be found here. Insiders sold a total of 11,947 shares of company stock worth $2,419,755 in the last 90 days. Company insiders own 0.30% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the company. RE Advisers Corp bought a new position in shares of CME Group in the second quarter worth $38,000. Capital Analysts LLC increased its holdings in shares of CME Group by 370.0% in the first quarter. Capital Analysts LLC now owns 188 shares of the financial services provider’s stock worth $38,000 after purchasing an additional 148 shares during the period. Glassman Wealth Services increased its holdings in shares of CME Group by 54.0% in the second quarter. Glassman Wealth Services now owns 191 shares of the financial services provider’s stock worth $41,000 after purchasing an additional 67 shares during the period. Eagle Bay Advisors LLC bought a new position in shares of CME Group in the second quarter worth $52,000. Finally, Patriot Financial Group Insurance Agency LLC increased its holdings in shares of CME Group by 32.1% in the second quarter. Patriot Financial Group Insurance Agency LLC now owns 317 shares of the financial services provider’s stock worth $67,000 after purchasing an additional 77 shares during the period. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Company Profile

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

See Also: What is a Reverse Stock Split?

Stock Target Advisor logo

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.